Short description
OliX is a clinical stage biotechnology company.
Description
OliX is a clinical stage biotechnology company, based on their own proprietary
RNA interference (RNAi) technology regulating the expression of disease-causing genes.
Last funding
Cannot Access
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Suwon, Ch'ungch'ong-namdo, South Korea, Asia
Founded on
February 26, 2010
Exited on
July 20, 2018
Went public on
July 20, 2018
Stock symbol
226950
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$7890 - 12340
Sign in for full access
Investors
Nopepepe, Blurry Noaccess, No Way, Uh Ohhhh, Absolutely Noaccess, Absolutely Noaccess
Sign in for full access
Founders
Dong-ki Lee